TOI.inRelated
Drug firm Divi's Laboratories on Saturday reported a 31.05 net profit of Rs 470.62 crore for the quarter ended December 2020, on account of robust sales.
The company had posted a net profit of Rs 359.09 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to the BSE.
Total income of the company on a consolidated basis stood at Rs 1,720.76 crore for the quarter under consideration.
It was Rs 1,437.93 crore for the same period a year ago, it added.
The company has been able to have normalised operations during the quarter, Divi's Laboratories said.
The company had posted a net profit of Rs 359.09 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to the BSE.
Total income of the company on a consolidated basis stood at Rs 1,720.76 crore for the quarter under consideration.
It was Rs 1,437.93 crore for the same period a year ago, it added.
The company has been able to have normalised operations during the quarter, Divi's Laboratories said.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
